Company news
Dawnrays Pharmaceutical Holdings Ltd. (HKEX:2348) news
Dawnrays Pharmaceutical Holdings Ltd. news releases on 6ix. Latest, Jun 18, 2026: DISCLOSEABLE TRANSACTION - INVESTMENT IN A LIMITED PARTNERSHIP
Press releases & updates
DISCLOSEABLE TRANSACTION - INVESTMENT IN A LIMITED PARTNERSHIP
June 18, 2026
Dawnrays Pharmaceutical : PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
April 19, 2021
Dawnrays Pharmaceutical : Next Day Disclosure Return
September 23, 2020
Dawnrays Pharmaceutical : SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO 2019 ANNUAL REPORT
August 20, 2020
Dawnrays Pharmaceutical : DISCLOSEABLE TRANSACTION-CONSTRUCTION AGREEMENTS
August 14, 2020
Dawnrays Pharmaceutical : Announcement of Interim Results for the six months ended 30 June 2017
August 22, 2017
Dawnrays Pharmaceutical : CHANGE IN BOARD LOT SIZE
August 4, 2017
Dawnrays Pharmaceuti : List of Directors and their Role and Function
March 30, 2012
Dawnrays Pharmaceuti : Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2011, Net Profit after Tax Dropped 12.3% to RMB 146.31 Million, A Final Dividend of HK$ 0.068 per Share was Declared
March 23, 2012
Dawnrays Pharmaceuti : Date of Board Meeting
March 5, 2012
Dawnrays Pharmaceuti : Voluntary Announcement New Product Pharmaceutical Registration Approval
December 20, 2011
Dawnrays Pharmaceuti : Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared
August 23, 2011